Tencent Partners with Pfizer to Launch Smart Healthcare Innovation Ecosystem – Zhang Yu Highlights “Dual-Engine” Strategy for Healthcare Digitization 
Pharnext: Reinforcement of Pharnext Equity Capital by Conversion of Convertibles Bonds
PARIS, FRANCE / ACCESSWIRE / March 6, 2019 / Pharnext SA (FR0011191287 - ALPHA), a biopharmaceutical company pioneering a new...
Zynex to Present at the 2019 LD Micro Virtual Conference
LOS ANGELES, CA / ACCESSWIRE / March 6, 2019 / Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing...
Aytu BioScience Announces ZolpiMist(TM) Global Distribution Agreement with SUDA Pharmaceuticals
Aytu Assumes Milestone & Royalty-Based Licensing Agreement with SUDA Pharmaceuticals to Sublicense ZolpiMist Outside of the United States and Canada...
Champions Oncology to Announce Third Quarter Financial Results on Monday, March 18, 2019
HACKENSACK, NJ / ACCESSWIRE / March 6, 2019 / Champions Oncology, Inc. (NASDAQ: CSBR), engaged in an end-to-end range of...
Alimera Sciences Announces the Reimbursement of ILUVIEN(R) in France
France is a Significant Market for Intravitreal Steroid Use ATLANTA, GA / ACCESSWIRE / March 6, 2019 / Alimera Sciences,...
Cerecor Announces $8 Million Bought Deal Offering
ROCKVILLE MD / ACCESSWIRE / March 5, 2019 / Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a...
Heat Biologics Lead Director to Chair Oncology Roundtable Discussion at WuXi Healthcare Forum in Shanghai
DURHAM, NC / ACCESSWIRE / March 5, 2019 / Heat Biologics, Inc. (NASDAQ: HTBX), a biopharmaceutical company developing "off-the-shelf" T-cell...
Jaguar Health, Inc. Reports Voting Results from February 28, 2019 Special Meeting of Stockholders
All Proposals ApprovedSAN FRANCISCO, CA / ACCESSWIRE / March 5, 2019 / Jaguar Health, Inc. (NASDAQ: JAGX) (''Jaguar'' or the...
Dynatronics to Participate in Canaccord’s 2019 Musculoskeletal Conference in Las Vegas, Nevada
COTTONWOOD HEIGHTS, UT / ACCESSWIRE / March 5, 2019 / Dynatronics Corporation (NASDAQ: DYNT), a leading provider of physical therapy,...
Pieris Pharmaceuticals to Host Full-Year 2018 Investor Call and Corporate Update on March 12, 2019
BOSTON, MA / ACCESSWIRE / March 5, 2019 / Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a biotechnology company advancing novel biotherapeutics...
Viveve to Present at Cowen and Company 39th Annual Health Care Conference
ENGLEWOOD, CO / ACCESSWIRE / March 5, 2019 / Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on...
Parallax Health Sciences Appoints Pete Scobell to Board of Advisors
Executive and former Navy SEAL brings leadership and telehealth marketing experience to Parallax SANTA MONICA, CA / ACCESSWIRE / March...
Women’s Risk of Colorectal Cancer Linked To Physical Inactivity
NEW YORK, NY / ACCESSWIRE / March 4, 2019 / Inactive and sedentary lifestyles have been consistently linked to both...
EViTRADE Appoints Investor Relations Firm – Updated
VANCOUVER, BC / ACCESSWIRE / March 4, 2019 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the "Company") is...
“Together Hand in Hand”: 14th IFSSH & 11th IFSHT Triennial Congress for Hand Surgery and Therapy in Berlin
Berlin – From 17 to 21 June 2019, the International Federation of Societies for Surgery of the Hand (IFSSH) and...
CorMedix Inc. Appoints Alan W. Dunton, M.D. to Board of Directors
BERKELEY HEIGHTS, NJ / ACCESSWIRE / March 4, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on...
Invitation to Year-End Results 2018 Conference Call of MorphoSys AG on March 14, 2019
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / March 4, 2019 / MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX & MDAX; Nasdaq:...
EViTRADE Appoints Investor Relations Firm
VANCOUVER, BC / ACCESSWIRE / March 4, 2019 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the "Company") is...
Adhera Therapeutics and Alyvant Enter into Digital Co-Promotion Agreement for Prestalia
RESEARCH TRIANGLE PARK, NC and NEW YORK, NY / ACCESSWIRE / March 4, 2019 / Adhera Therapeutics (OTCQB: ATRX), a...
Xenetic Biosciences, Inc. (NASDAQ: XBIO) Announces Agreement to Acquire Innovative CAR T Technology Platform
Innovative XCART platform with demonstrated proof of mechanism and preclinical evidence of target specificity positions Xenetic to address high value...